Abstract
Introduction: Rural whānau (families) in Aotearoa New Zealand face persistent barriers to timely healthcare, contributing to inequities - particularly for Māori. Point-of-care testing offers a potential solution by bringing diagnostic services closer to communities. To investigate this potential, the study 'He Tapu te Whare Tangata: A Model for Empowering Rural Solutions for Cervical Cancer Prevention' used human papillomavirus-based screening to examine how point-of-care testing could strengthen cervical screening pathways for rural women. The study combined a cluster-randomised crossover trial with qualitative research to compare two screening pathways, one of which utilised molecular point-of-care testing with direct access to specialist colposcopy appointments.
Aim: This paper explores the acceptability and feasibility of point-of-care testing for human papillomavirus in rural primary care from the perspective of healthcare professionals.
Methods: This paper draws on 11 interviews with rural primary healthcare professionals who spoke to the implementation and delivery of point-of-care testing. Guided by a Kaupapa Māori approach, semi-structured interviews were conducted between 2021 and 2023. Reflexive thematic analysis guided data interpretation.
Results: Interviewees considered point-of-care testing valuable for enabling faster results, timelier care, and more co-ordinated pathways. Community control was perceived to enhance rural service resilience - particularly during extreme weather when access to central laboratories was disrupted. Successful implementation was considered dependent on sufficient resourcing, workforce training, and sustained support.
Conclusion: Point-of-care testing for cervical screening was acceptable and, with adequate support, feasible in rural general practice. Point-of-care testing offers an equity-enhancing model for improving access and outcomes for rural Māori communities.